Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Diseases”

Showing 20 of 0 results

Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Not applicableStudy completedNCT00357578
What this trial is testing

Genetic Study of Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 150
Not applicableEnded earlyNCT02625376
What this trial is testing

Resveratrol for Exudative Age-Related Macular Degeneration

Who this might be right for
AMDAge-related Macular DegenerationChoroidal Neovascularisation
Poitiers University Hospital 25
Not applicableStudy completedNCT06729723
What this trial is testing

Exploratory Study on the Effect of SAT-001 on Choroidal Thickness in Pediatric Myopia Patients

Who this might be right for
Myopia
S-Alpha Therapeutics, Inc. 20
Not applicableStudy completedNCT01542866
What this trial is testing

A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration (AMD)
Novartis Pharmaceuticals 160
Not applicableStudy completedNCT01025063
What this trial is testing

Use of Spectral OCT in Combination Therapy

Who this might be right for
Choroidal Neovascularization
Barnes Retina Institute 15
Not applicableUnknownNCT05623293
What this trial is testing

Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis

Who this might be right for
Choroid DiseaseCarotid StenosisCarotid Atherosclerosis+1 more
Universidade do Porto 40
Not applicableUnknownNCT05258032
What this trial is testing

Structural and Functional Characterization of Rare Ocular Diseases

Who this might be right for
Retinitis PigmentosaStargardt Disease 1Best Disease+2 more
Barcelona Macula Foundation 50
Testing effectiveness (Phase 2)Study completedNCT00244816
What this trial is testing

Taxoprexin® Treatment for Advanced Eye Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 22
Large-scale testing (Phase 3)Study completedNCT03496012
What this trial is testing

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

Who this might be right for
Choroideremia
Biogen 169
Post-approval studies (Phase 4)Study completedNCT00504959
What this trial is testing

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD)
Novartis 234
Not applicableStudy completedNCT00006188
What this trial is testing

Evaluation and Treatment of Patients With Inflammatory Eye Diseases

Who this might be right for
ChoroiditisIridocyclitisIritis+1 more
National Eye Institute (NEI) 300
Not applicableUnknownNCT04499768
What this trial is testing

A Longitudinal Study of Choroidal Changes After Cataract Surgery in Eyes With Diabetic Retinopathy

Who this might be right for
Optical Coherence TomographyDiabetic RetinopathyChoroid
Ruijin Hospital 46
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Not applicableStudy completedNCT00343603
What this trial is testing

Tracking Optical Coherence Tomography

Who this might be right for
Macular DegenerationGlaucomaDiabetic Retinopathy+1 more
University of Pittsburgh 100
Post-approval studies (Phase 4)UnknownNCT01657669
What this trial is testing

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Who this might be right for
Age Related Macular Degeneration
Retina Research Institute, LLC 22
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Not applicableStudy completedNCT00379795
What this trial is testing

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Who this might be right for
Choroidal Neovascularization, Age-related Macular Degeneration
Genentech, Inc. 853
Testing effectiveness (Phase 2)Study completedNCT01023295
What this trial is testing

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Mateon Therapeutics 20
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation